Oct 6, 2013
Recent Study: Commonwealth Biotechnologies, Inc. (RNN) -...
Commonwealth Biotechnologies, Inc. is a specialized life sciences company engaged in providing macromolecular synthetic and analytical technologies in the areas of bio-defense, laboratory support, and contract research.
AIBioTech Announces Promotion of VP of DNA Services
AIBioTech is proud to announce the promotion Greg Meyers to Vice President of DNA Services.
HedgePath Pharmaceuticals, Inc. Completes Reorganization Plan with Commonwealth Biotechnologies
As a new public company, HPPI will continue its program to initiate the clinical development of itraconazole as an anti-fungal agent) to re-purpose it and evaluate its potential as a treatment for cancer, with an initial focus on skin, prostate and lung cancers in the U.S. market.
Commonwealth Biotechnologies, Inc. Says It has Emerged From Chapter 11
Commonwealth Biotechnologies, Inc. announced today that its Plan of Reorganization from Chapter 11 bankruptcy proceedings has become effective April 15, 2013.